[Federal Register Volume 71, Number 97 (Friday, May 19, 2006)]
[Notices]
[Page 29155]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E6-7635]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panels (SEP): Industrial Costs of Developing and 
Commercializing Childhood Vaccines, Request for Applications (RFA) IP 
06-010

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting:

    Name: Disease, Disability, and Injury Prevention and Control 
Special Emphasis Panel (SEP): Industrial Costs of Developing and 
Commercializing Childhood Vaccines, RFA IP 06-010.
    Time and Date: 12 p.m.-4 p.m., June 29, 2006 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c) (4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to 
``Industrial Costs of Developing and Commercializing Childhood 
Vaccines,'' RFA IP 06-010.
    For Further Information Contact: Christine Morrison, Ph.D., 
Scientific Review Administrator, Office of Extramural Research, CDC, 
1600 Clifton Road NE, Mailstop D72, Atlanta, GA 30333, Telephone 
(404) 639-3098.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: May 11, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. E6-7635 Filed 5-18-06; 8:45 am]
BILLING CODE 4163-18-P